In contrast, Li et al.60 reported that hepatocyte-specific METTL3 deletion drives NAFLD-to-NASH progression by enhancing CD36-mediated hepatic-free FA uptake and CCL2-induced inflammation. Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.